Eventide Healthcare & Life Sciences Fund CLASS C SHARES (ETCHX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
27.12
+0.01 (0.04%)
Apr 25, 2025, 4:00 PM EDT
-10.02% (1Y)
| Fund Assets | 1.82B |
| Expense Ratio | 2.32% |
| Min. Investment | $1,000 |
| Turnover | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 27.11 |
| YTD Return | -7.25% |
| 1-Year Return | -10.02% |
| 5-Year Return | -9.87% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | n/a |
| Holdings | 86 |
| Inception Date | Dec 27, 2012 |
About ETCHX
The Eventide Healthcare & Life Sciences Fund CLASS C SHARES (ETCHX) seeks to provide long-term capital appreciation. ETCHX will invest at least 80% of its net assets, plus borrowings for investment purposes, in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt.
Category Health
Stock Exchange NASDAQ
Ticker Symbol ETCHX
Share Class Class C Shares
Index S&P Biotechnology Select Industry TR
Performance
ETCHX had a total return of -10.02% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.56%.
Top 10 Holdings
33.84% of assets| Name | Symbol | Weight |
|---|---|---|
| Verona Pharma plc | VRNA | 4.41% |
| Scholar Rock Holding Corporation | SRRK | 3.97% |
| Mirum Pharmaceuticals, Inc. | MIRM | 3.73% |
| US BANK MMDA - USBGFS 9 | n/a | 3.68% |
| Insmed Incorporated | INSM | 3.60% |
| Guardant Health, Inc. | GH | 3.43% |
| Blueprint Medicines Corporation | BPMC | 2.93% |
| Collegium Pharmaceutical, Inc. | COLL | 2.85% |
| Celldex Therapeutics, Inc. | CLDX | 2.65% |
| Aura Biosciences, Inc. | AURA | 2.59% |